|
==Overview== Biocompatibles International plc is a medical technology company in the field of drug-device combination products. Approved oncology products are supplied and marketed from facilities in Farnham, Surrey, UK and Oxford CT, USA. The product range includes Drug-Eluting Bead products which are used in more than 35 countries for the treatment of primary liver cancer (HCC), liver metastases from colorectal cancer, and other cancers. The company also supplies and markets Brachytherapy products (Radiation-Delivering Seeds) which are used in the treatment of prostate cancer. Biocompatibles’ UK research and development facilities are engaged in licensing and in new product development, based on the company's core drug delivery technologies in the treatment of cancers.. Cellmed in Alzenau, Germany, is developing a Drug-Eluting Bead product for the treatment of stroke, based on proprietary stem cell technology. Cellmed is also developing a () analogue for the treatment of () and () partnered with (). Biocompatibles also has collaborative agreements with Bayer HealthCare Pharmaceuticals Inc., Medtronic Inc. and Merz Pharma. 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Biocompatibles」の詳細全文を読む スポンサード リンク
|